Pharma
Say goodbye to trypanophobia—this biotech is trying to turn injectable drugs into pills
CEO Talat Imran says RaniPill could get its first approval in three years.
Stay updated on Biologics trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Biologics's role in Biotech & Emerging Modalities and Pharma.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.